Stoke Therapeutics, Inc. (STOK) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Stoke Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.533 Hello and welcome to the Stoke Therapeutics Second Quarter 2026 Business and Financial 00:00:05.533 -- 00:00:09.954 Update. At this time, all participants are in a listen-only mode. 00:00:09.954 -- 00:00:14.075 After the speaker presentation, there will be a question and answer session. 00:00:14.075 -- 00:00:19.837 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:19.837 -- 00:00:23.718 You will then hear an automated message advising your hand has been raised. 00:00:23.718 -- 00:00:27.563 To withdraw your question, please press star 11 again. 00:00:27.563 -- 00:00:31.305 Please be advised that today's conference is being recorded. 00:00:31.305 -- 00:00:36.646 It is now my pleasure to introduce CFO Thomas Leggett. 00:00:38.767 -- 00:00:43.129 Good evening and welcome to Stoke Therapeutics second quarter 2026 business update conference 00:00:43.129 -- 00:00:47.471 call. I'm Thomas Leggett, the Chief Financial Officer of Stoke Therapeutics. 00:00:47.471 -- 00:00:51.473 Joining me on today's call are Ian Smith, our Chief Executive Officer, Dr. 00:00:51.473 -- 00:00:56.001 Barry Tico, Chief Medical Officer, and Jason Hoitt, Chief Patient Officer. 00:00:56.001 -- 00:01:00.045 As a reminder, today's webcast presentation is available in the Investors section of 00:01:00.045 -- 00:01:04.268 our website. This webcast is being recorded and will be available for replay later this 00:01:04.268 -- 00:01:05.849 evening. 00:01:05.849 -- 00:01:10.193 Before we begin, please note that today's discussion includes forward-looking statements. 00:01:10.193 -- 00:01:14.137 These forward-looking statements are subject to risks and uncertainties, and actual results 00:01:14.137 -- 00:01:19.940 may differ materia...